Hematologist/oncologists Dr. Charles Farber and Dr. Michael Anthony Scola have joined Atlantic Hematology Oncology, a part of Atlantic Health System Cancer Care.
Both physicians are long-time members of the Morristown Medical Center cancer care community.
Farber will continue as a general oncologist with a concentration in malignant hematology and will serve as medical director of Oncology Research Network Development for Atlantic Health System, of which the Breakthrough Oncology Accelerator is a key component.
The BOA is a new partnership with Atlantic Health System, Translational Genomics Research Institute (TGen) and OriginCV to expand and improve access to cancer research and treatments.
Scola, who maintains a broad-based clinical practice with a focus on hematology, has been appointed director of the Atlantic Thrombosis Center – a new multidisciplinary program to investigate and optimize clinical care of blood clotting risk, events and disorders. A key feature of this Center will be its collaborative work with expert physicians at Morristown Medical Center.
Farber became an attending physician at Morristown Medical Center in 1995 and served as chief of the Division of Hematology/Oncology at the hospital’s Carol G. Simon Cancer Center from 2007-2011. Scola joined the staff at Morristown in 2002.
Both physicians spent two years at Summit Medical Group – MD Anderson Cancer Center before joining Atlantic Hematology Oncology.
“Our hematology/oncology patients, physicians and staff are very familiar with the skill, dedication and compassion of Drs. Farber and Scola,” said Dr. Missak Haigentz Jr., medical director, Atlantic Hematology Oncology. “They have been highly regarded members of the Morristown Medical Center community for many years, and we look forward to their new leadership in Atlantic Medical Group and Atlantic Health System.”
The new offices for both doctors are located at the Carol G. Simon Cancer Center at Morristown Medical Center. For more information, call 973-971-7960.